Lexaria Bioscience Corp. - LEXX

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$1.045M
QoQ value delta ($000)
-$573K (-35.41%)
Implied price effect (QoQ)
-35.08%
Shares
Total shares
1,701,210
QoQ shares delta
-8,837 (-0.52%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (LEXX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 31 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Invenomic Capital Management LP 290 470,915 0.01%
UBS Group AG 222 361,300 0.0%
VANGUARD GROUP INC 159 258,816 0.0%
GEODE CAPITAL MANAGEMENT, LLC 135 219,718 0.0%
TORONTO DOMINION BANK 86 140,013 0.0%
Byrne Asset Management LLC 65 105,500 0.04%
STATE STREET CORP 24 39,301 0.0%
BlackRock, Inc. 16 27,445 0.0%
Krilogy Financial LLC 15 19,653 0.0%
NORTHERN TRUST CORP 11 18,389 0.0%
RENAISSANCE TECHNOLOGIES LLC 9 15,600 0.0%
BANK OF MONTREAL /CAN/ 8 14,083 0.0%
ROYAL BANK OF CANADA 4 7,283 0.0%
OSAIC HOLDINGS, INC. 1 2,195 0.0%
BANK OF AMERICA CORP /DE/ 0 203 0.0%
MORGAN STANLEY 0 3 0.0%
MAI Capital Management 0 200 0.0%
Tower Research Capital LLC (TRC) 0 32 0.0%
GABLES CAPITAL MANAGEMENT INC. 0 13 0.0%
Farther Finance Advisors, LLC 0 166 0.0%
Federation des caisses Desjardins du Quebec 0 382 0.0%